Drug combination for treating rheumatism arthritis and preparation method thereof

A technology for arthritis and rheumatoid arthritis, which is applied in the field of pharmaceutical compositions for the treatment of rheumatoid arthritis and its preparation, and can solve problems such as the lack of formulation studies and pharmacological mechanisms of action, and the inability to provide clinical references, etc.
CN106540044AActive Publication Date: 2017-03-29湖北领康中药材有限公司
5 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
湖北领康中药材有限公司
Publication Date
2017-03-29

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a drug combination for treating rheumatism arthritis and a preparation method thereof. The drug combination for treating rheumatism arthritis comprises, by weight, 10-30 parts of panax japonicas, 10-30 parts of astilbe chinensis, 10-30 parts of paris polyphylla, 20-60 parts of clematis henryi oliv, 15-45 parts of toddalia asiatualam and 15-45 parts of Indian damnacanthus herbs. The preparation method includes the steps that raw medicines are weighed separately and subjected to 160-mesh sieving, and the raw medicines are obtained; and the raw medicines including the panax japonicas, the astilbe chinensis, the paris polyphylla, the clematis henryi oliv, the astilbe chinensis and the Indian damnacanthus herbs are mixed evenly, and the drug combination for treating rheumatism arthritis is obtained. The drug combination for treating rheumatism arthritis has the effects of dispelling wind, eliminating dampness, dispersing blood stasis, relieving pain, promoting qi to activate blood, warming and activating meridian, and achieving nourishing and strengthening, has significant clinical effects and has no obvious toxic or side effects. The drug combination for treating rheumatism arthritis has a significant therapeutic effect on arthritis induced by a complete Freund's adjuvant, has good anti-inflammatory and analgesic effects, achieves the pharmacological function significantly superior to that of a single medicinal material and other compatible combinations, plays a synergetic interaction and has low toxic and side effects.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of treating rheumatoid arthritis, and in particular relates to a pharmaceutical composition for treating rheumatoid arthritis and a preparation method thereof. Background technique

[0002] Rheumatoid arthritis (Rheumatism Arthritis, RA) is a chronic, systemic autoimmune disease characterized by joint synovitis, with chronic, symmetrical, polysynovial arthritis and extra-articular lesions as the main clinical manifestations , occurs in small joints such as hands, wrists, and feet, and its etiology may be related to differences in geography, endocrine, nutrition, occupation, psychology, and social environment, bacterial and viral infections, and genetic factors. In the early stage, the joints are red, swollen, hot, painful, and dysfunctional, and in the late stage, the joints may be stiff and deformed in varying degrees, accompanied by atrophy of bones and skeletal muscles, which is very easy to cause disabil...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More